MedPath

The effects of rapid acting insulin on glucose control in basal-bolus insulin treated type2 diabetes.

Not Applicable
Recruiting
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000012302
Lead Sponsor
Tokyo Medical University Hachioji Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with hypersensitivity to insulin Aspart and/or Lispro. 2) Patients with surgical operation, trauma or infection. 3) Patients who are pregnant 4) Patients with severe renal or liver failure 5) Patients with pituitary insufficiency or adrenal insufficiency. 6) Patients with diarrhea or vomit 7) Patients with heavy exercise 8) Juged as ineligible by clinical investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the value of makers for glycemic control
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath